Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria

This publication has 26 references indexed in Scilit:

• Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Study
  Transplantation and Cellular Therapy, 2019
• Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab
  Transplantation and Cellular Therapy, 2019
• Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones
  Transplantation and Cellular Therapy, 2019
• Eculizumab Bridging before Bone Marrow Transplant for Marrow Failure Disorders Is Safe and Does Not Limit Engraftment
  Transplantation and Cellular Therapy, 2018
• Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single‐center study
  Hematological Oncology, 2016
• Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study
  American Journal of Hematology, 2015
• Should I Transplant This Patient with Paroxysmal Nocturnal Hemoglobinuria? a Cost-Effectiveness Analysis of Eculizumab Versus Allogeneic Stem Cell Transplant
  Blood, 2014
• Long-Term Outcome of Fludarabine-Based Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Debilitating Paroxysmal Nocturnal Hemoglobinuria
  Transplantation and Cellular Therapy, 2014
• Diagnosis and management of paroxysmal nocturnal hemoglobinuria
  Blood, 2005
• Bone marrow transplants for paroxysmal nocturnal haemoglobinuria
  British Journal of Haematology, 1999